 |
|
Implantable Programmable Insulin Pumps for the Treatment of Diabetes
Kenneth Waxman, MD;
Dee Turner, RN-C, CDE, MSN;
Steve T. Nguyen;
Jean Louis Selam, MD;
M. Arthur Charles, MD, PhD
Arch Surg. 1992;127(9):1032-1037.
Abstract
• Implantable programmable pump systems for insulin delivery to the peritoneal cavity or for intravenous insulin delivery have been recently developed. Thirty-one pumps were implanted in 25 patients between 1987 and 1991. At this writing, 76% of patients had functioning pumps. Ninety-two percent of pumps were functioning at 1 year; 89% at 2 years; and 50% at 3 years. No life-threatening complications, either surgical or metabolic, developed. However, 18 patients required 23 outpatient procedures for maintenance of pump function or for pump removal. Metabolic improvement was evidenced by mean and standard deviation of blood glucose levels and by glycosylated hemoglobin levels.
(Arch Surg. 1992;127:1032-1037)
Author Affiliations
From the Department of Surgery (Dr Waxman) and Diabetes Research Program (Ms Turner, Mr Nguyen, and Drs Selam and Charles), University of California—Irvine, Orange.
Footnotes
Accepted for publication May 23, 1992.
Presented at the 63rd Annual Meeting of the Pacific Coast Surgical Association, Kauai, Hawaii, February 18, 1992.
Reprint requests to University of California—Irvine Medical Center, 101 City Dr S, Orange, CA 92668 (Dr Waxman).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
|
